These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 15735202)
1. Identification of Amadori-modified plasma proteins in type 2 diabetes and the effect of short-term intensive insulin treatment. Jaleel A; Halvatsiotis P; Williamson B; Juhasz P; Martin S; Nair KS Diabetes Care; 2005 Mar; 28(3):645-52. PubMed ID: 15735202 [TBL] [Abstract][Full Text] [Related]
2. Preferential recognition of Amadori-rich lysine residues by serum antibodies in diabetes mellitus: role of protein glycation in the disease process. Ansari NA; Moinuddin ; Alam K; Ali A Hum Immunol; 2009 Jun; 70(6):417-24. PubMed ID: 19332092 [TBL] [Abstract][Full Text] [Related]
3. [Transcapillary filtration of plasma proteins in patients with diabetes type II microangiopathy complications]. Muszyńska-Lachota I Ann Acad Med Stetin; 2002; 48():255-69. PubMed ID: 14601482 [TBL] [Abstract][Full Text] [Related]
4. Plasma Proteins Modified by Advanced Glycation End Products (AGEs) Reveal Site-specific Susceptibilities to Glycemic Control in Patients with Type 2 Diabetes. Greifenhagen U; Frolov A; Blüher M; Hoffmann R J Biol Chem; 2016 Apr; 291(18):9610-6. PubMed ID: 26933035 [TBL] [Abstract][Full Text] [Related]
5. A practical insulin infusion algorithm for the establishment of euglycaemia in both lean and obese patients with type 1 and type 2 diabetes. Stork AD; Erkelens DW; Veneman TF Diabetes Res Clin Pract; 2006 Jun; 72(3):251-7. PubMed ID: 16325299 [TBL] [Abstract][Full Text] [Related]
6. Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries. Schalkwijk CG; Ligtvoet N; Twaalfhoven H; Jager A; Blaauwgeers HG; Schlingemann RO; Tarnow L; Parving HH; Stehouwer CD; van Hinsbergh VW Diabetes; 1999 Dec; 48(12):2446-53. PubMed ID: 10580435 [TBL] [Abstract][Full Text] [Related]
7. The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Yu JG; Javorschi S; Hevener AL; Kruszynska YT; Norman RA; Sinha M; Olefsky JM Diabetes; 2002 Oct; 51(10):2968-74. PubMed ID: 12351435 [TBL] [Abstract][Full Text] [Related]
8. Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects. Kruszynska YT; Yu JG; Olefsky JM; Sobel BE Diabetes; 2000 Apr; 49(4):633-9. PubMed ID: 10871202 [TBL] [Abstract][Full Text] [Related]
9. Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects. Frias JP; Yu JG; Kruszynska YT; Olefsky JM Diabetes Care; 2000 Jan; 23(1):64-9. PubMed ID: 10857970 [TBL] [Abstract][Full Text] [Related]
10. Effect of exogenous insulin on protein metabolism with differing nonprotein energy intakes in Type 2 diabetes mellitus. Gougeon R; Marliss EB; Jones PJ; Pencharz PB; Morais JA Int J Obes Relat Metab Disord; 1998 Mar; 22(3):250-61. PubMed ID: 9539194 [TBL] [Abstract][Full Text] [Related]
11. [Assays of HbA1c and Amadori products in human biology]. Gillery P Ann Pharm Fr; 2014 Sep; 72(5):330-6. PubMed ID: 25220229 [TBL] [Abstract][Full Text] [Related]
12. Effects of heparin treatment on hemostatic abnormalities in obese non-insulin-dependent diabetic patients. Avellone G; di Garbo V; Cordova R; Rotolo G; Raneli G; de Simone R; Bompiani G Metabolism; 1997 Aug; 46(8):930-4. PubMed ID: 9258277 [TBL] [Abstract][Full Text] [Related]
13. U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group. Diabetes; 1995 Nov; 44(11):1249-58. PubMed ID: 7589820 [TBL] [Abstract][Full Text] [Related]
14. Glycaemic control improves fibrin network characteristics in type 2 diabetes - a purified fibrinogen model. Pieters M; Covic N; van der Westhuizen FH; Nagaswami C; Baras Y; Toit Loots D; Jerling JC; Elgar D; Edmondson KS; van Zyl DG; Rheeder P; Weisel JW Thromb Haemost; 2008 Apr; 99(4):691-700. PubMed ID: 18392327 [TBL] [Abstract][Full Text] [Related]
15. Short-term intensive insulin therapy in newly diagnosed type 2 diabetes. Ryan EA; Imes S; Wallace C Diabetes Care; 2004 May; 27(5):1028-32. PubMed ID: 15111515 [TBL] [Abstract][Full Text] [Related]
16. Synthesis rate of muscle proteins, muscle functions, and amino acid kinetics in type 2 diabetes. Halvatsiotis P; Short KR; Bigelow M; Nair KS Diabetes; 2002 Aug; 51(8):2395-404. PubMed ID: 12145150 [TBL] [Abstract][Full Text] [Related]
17. Non-enzymatic glucosylation induced neo-epitopes on human serum albumin: A concentration based study. Neelofar K; Arif Z; Ahmad J; Alam K PLoS One; 2017; 12(2):e0172074. PubMed ID: 28192530 [TBL] [Abstract][Full Text] [Related]
18. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. Graham TE; Yang Q; Blüher M; Hammarstedt A; Ciaraldi TP; Henry RR; Wason CJ; Oberbach A; Jansson PA; Smith U; Kahn BB N Engl J Med; 2006 Jun; 354(24):2552-63. PubMed ID: 16775236 [TBL] [Abstract][Full Text] [Related]
19. Rat tissue collagen modified by advanced glycation: correlation with duration of diabetes and glycemic control. Turk Z; Misur I; Turk N; Benko B Clin Chem Lab Med; 1999 Aug; 37(8):813-20. PubMed ID: 10536930 [TBL] [Abstract][Full Text] [Related]
20. Long-term glycemic control relates to mortality in type II diabetes. Andersson DK; Svärdsudd K Diabetes Care; 1995 Dec; 18(12):1534-43. PubMed ID: 8722048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]